Mar. 15, 2013 — Low and moderate drinkers of alcohol reported lower severity of symptoms of fibromyalgia than teetotallers, finds a study in BioMed Central’s open access journal Arthritis Research & Therapy. Too much alcohol reversed this effect.
The chronic pain of fibromyalgia is thought to affect one in 20 people worldwide but there is no known cause or cure. It often goes hand in hand with fatigue and sleep problems, headaches, depression and irritable bowel and bladder problems. Treatment is based around pain management and lifestyle changes.
Making the journey from patient to person takes time. The isolation and fear that can overwhelm a person with chronic pain grows over time. And the return to a fuller, more rewarding life also takes time.
It’s a journey with many phases. The ACPA describes these phases as Ten Steps.
The ACPA’s Ten Steps For Moving From Patient To Person.
STEP 1: Accept the Pain
Learn all you can about your physical condition. Understand that there may be no current cure and accept that you will need to deal with the fact of pain in your life.
STEP 2: Get Involved
Take an active role in your own recovery. Follow your doctor’s advice and ask what you can do to move from a passive role into one of partnership in your own health care.
By Karen Lee Richards, Health Guide
People who have fibromyalgia, ME/CFS (chronic fatigue syndrome), chronic pain and any number of other chronic illnesses are in serious danger of being labeled as having a mental disorder.
The 5th edition of the Diagnostic and Statistical Manual of Mental Disorders, commonly known as the DSM-5, is about to go to the printers and is scheduled to be released in May 2013. The DSM is published by the American Psychiatric Association (APA) and contains the diagnostic codes used by doctors for mental disorders. Continue reading
I came across this post on a site debating of all things gun laws. I remembered when I was younger the City were I grew up closing down the mental health facilities and thinking this must be wonderful, The new medications were curing the patients. Little did I know so on to Joe Schlosser’s post:
Joseph Schlosser December 17, 2012 at 4:16 am
The common thread of what can be done to prevent the slaughter of innocents is;
What can we do to prevent this from happening again?
In as much as evil does exist and that alone could qualify as a reason for this
horror, we can assess a few other things. Continue reading
The U.S. Food and Drug Administration has approved the use of the first opioid painkiller for the treatment of neuropathic pain caused by diabetic peripheral neuropathy. Nucynta, which is made by Janssen Pharmaceuticals, is already approved for management of moderate to severe chronic pain in adults.
The expanded approval from the FDA allows Janssen, a division of Johnson & Johnson (NYSE: JNJ), to market Nucynta for pain relief to nearly 8 million Americans who have diabetic peripheral neuropathy (DPN). The expanded use comes at a time when the FDA is being petitioned by some physicians and public health officials toreduce the approved uses of opioids, not expand them. Continue reading
Marijuana bills are being passed all over the country!! I am proud to say that here in Massachusetts we have finally gotten a medicinal bill passed. On the downside, we are a commonwealth not a state and this means that our beloved (lol) politicians can simply ignore the vote as they have done in the past on other bills. Continue reading
First published: March 16, 2011; This version published: 2011; Review content assessed as up-to-date: February 15, 2011.
Plain language summary
Antiepileptic drugs like gabapentin are commonly used for treating neuropathic pain, usually defined as pain due to damage to nerves. This would include postherpetic neuralgia (persistent pain experienced in an area previously affected by shingles), painful complications of diabetes, nerve injury pain, phantom limb pain, fibromyalgia and trigeminal neuralgia. This type of pain can be severe and long‐lasting, is associated with lack of sleep, fatigue, and depression, and a reduced quality of life. Continue reading
FRIDAY, June 22 (HealthDay News) — About 10 percent of fibromyalgia patients use marijuana to relieve symptoms such as pain, fatigue and insomnia, a new study has found.
Fibromyalgia is a chronic condition that causes widespread pain, fatigue, headaches, sleep disturbances and other symptoms. It affects up to 3 percent of people and is more common among women.
Standard drug treatments for fibromyalgia-related pain provide only modest relief, and some patients self-medicate with marijuana and other traditional therapies, said Dr. Mary-Ann Fitzcharles, a professor of medicine at McGill University and consulting rheumatologist at the Montreal General Hospital of the McGill University Health Centre in Montreal. Continue reading